Skip to main content
. 2021 Jun 21;3(1):vdab083. doi: 10.1093/noajnl/vdab083

Table 1.

Patient Baseline Characteristics and Comorbidities

Characteristic n (%) Cohort P-value
All Age 65–74 Age 75+
Total # of patients 150 79 71 .42
Age at diagnosis in years
Mean 74.5 69.4 80.1 <.0001
Median 74 70 79
Range 65–94 65–74 75–94
Sex
Males 79 (52.7) 43 (54.4) 36 (50.7) .77
Females 71 (47.3) 36 (45.6) 35 (49.3)
Preop KPS
Mean 77.5 76.6 78.6 .37
Median 80 80 80
Range 10–100 10–100 50–100
Comorbidities
Hypertension 90 (60) 43 (54.4) 47 (66.2) .04
Diabetes 30 (20) 10 (12.7) 20 (28.2) .03
Dyslipidemia 53 (35.3) 30 (38) 23 (32.4)
Atrial fibrillation 10 (6.7) 3 (3.8) 7 (9.9)
Cardiovascular disease 29 (19.3) 11 (13.9) 18 (25.4)
COPD 7 (4.7) 3 (3.8) 4 (5.6)
Smoker 21 (14) 16 (20.3) 5 (7) .04
Other CNS disease 27 (18) 17 (21.5) 10 (14.1)
Other cancer 34 (22.7) 14 (17.7) 20 (28.2)
Mean # of comorbidities 2 1.8 2.2 .18
# With any comorbidities 124 (82.7) 64 (81) 60 (84.5) .73
# With multiple comorbidities 82 (54.7) 39 (49.4) 43 (60.6) .22

Significant values (P-value < 0.05) are given in bold.